Merchavia Holdings and Investments Ltd

MRHLTASEIL0002570146₪37M

Investment Thesis

Generates returns by investing in biomed, MedTech, and life-sciences portfolio companies and realizing value through fair-value remeasurement and potential exits. Also earns operating income by marketing and distributing diagnostic test kits through exclusive distribution arrangements.

Geographic Exposure

IsraelN/A

CyprusN/A

GreeceN/A

KazakhstanN/A

United Arab EmiratesN/A

PolandN/A

Revenue Drivers

Biomed and MedTech investing

Minority investments in medical technology companies held at fair value.

PERIPHERAL0%

Diagnostic test kit distribution

Marketing and distribution of diagnostic test kits under exclusive arrangements.

PERIPHERAL0%

End Markets

Healthcare providers and diagnostic laboratories
Medical device and digital health customers (via portfolio companies)
Patients referred for diagnostic testing
Strategic partners and co-investors (venture ecosystem)

Specializations

Fair value measurement of portfolio investments (IFRS)Venture-capital style deal sourcing and due diligenceExclusive distribution agreementsClinical trials and evidence generation (portfolio companies)Medical device and diagnostics regulatory pathways (FDA, CE)Laboratory-developed test commercialization and oversight (CLIA/LDT context)+2 more

Activities

Venture deal sourcing and screening
Due diligence and investment execution
Portfolio oversight and value-add support (including board representation)
Marketing and distribution via subcontractors/exclusive agreements
Capital raising and liquidity management